Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 242,077 | 399,266 | 276,472 | 869,191 | 397,664 |
| Marketable Securities | 2,055,579 | 1,931,935 | 1,710,397 | 1,245,782 | 1,494,711 |
| Receivables | 92,188 | 97,778 | 25,538 | 61,896 | 76,204 |
| Inventories | 12,512 | 7,441 | 22,033 | 24,806 | 21,965 |
| Other current assets | 217,934 | 205,433 | 168,254 | 143,374 | 140,163 |
| TOTAL | $2,620,290 | $2,641,853 | $2,202,694 | $2,345,049 | $2,130,707 |
| Non-Current Assets | |||||
| PPE Net | 94,251 | 71,043 | 74,294 | 178,069 | 181,077 |
| Intangibles | 0 | 0 | 0 | 0 | 27,937 |
| Other Non-Current Assets | 289,134 | 277,176 | 256,888 | 88,572 | 50,034 |
| TOTAL | $383,385 | $348,219 | $331,182 | $266,641 | $259,048 |
| Total Assets | $3,003,675 | $2,990,072 | $2,533,876 | $2,611,690 | $2,389,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 44,332 | N/A | N/A | 316,110 |
| Accounts payable and accrued liabilities | 42,964 | 26,027 | 17,921 | 11,904 | 17,199 |
| Accrued Expenses | 178,052 | 215,621 | 189,279 | 127,370 | 155,889 |
| Other current liabilities | 9,279 | 8,831 | 7,535 | 3,526 | N/A |
| TOTAL | $309,318 | $448,090 | $311,561 | $240,550 | $598,898 |
| Non-Current Liabilities | |||||
| Long Term Debt | 51,924 | 41,836 | 15,973 | 6,946 | 23,409 |
| Deferred Revenues | 78,989 | 151,128 | 90,577 | 97,714 | 108,376 |
| Other Non-Current Liabilities | 1,897,578 | 1,872,276 | 1,345,687 | 1,240,578 | 635,600 |
| TOTAL | $2,106,006 | $2,155,296 | $1,649,428 | $1,599,403 | $1,047,575 |
| Total Liabilities | $2,415,324 | $2,603,386 | $1,960,989 | $1,839,953 | $1,646,473 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 158,965 | 145,752 | 142,954 | 141,689 | 140,862 |
| Common Shares | 158 | 144 | 142 | 141 | 140 |
| Retained earnings | -2,249,808 | -1,795,911 | -1,429,625 | -1,159,903 | -1,131,306 |
| Other shareholders' equity | -30,811 | -32,645 | -57,480 | -32,668 | -21,071 |
| TOTAL | $588,351 | $386,686 | $572,887 | $771,737 | $743,282 |
| Total Liabilities And Equity | $3,003,675 | $2,990,072 | $2,533,876 | $2,611,690 | $2,389,755 |